基于MRI的影像组学列线图预测肺腺癌脊柱转移灶EGFR外显子19和21突变
本研究纳入76例肺腺癌脊柱转移患者,从T1WI和T2WI脂肪抑制序列提取影像组学特征,构建整合影像组学特征、年龄和CEA水平的列线图,用于鉴别EGFR外显子19与21突变。列线图在训练集和验证集的AUC分别为0.90和0.88,优于临床模型,决策曲线分析证实其临床实用性。
要点
- 脊柱转移灶MRI影像组学列线图可辅助鉴别EGFR外显子19与21突变。
- 列线图整合了影像组学特征、年龄和CEA水平,预测性能优于单纯临床模型。
- 该工具为肺腺癌个体化治疗提供潜在的无创评估手段。
局限性
- 单中心回顾性研究,样本量较小(76例)。
- 未报告外部验证队列。
- 原文未详细说明影像组学特征的具体提取与筛选流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Preoperative identifications of epidermal growth factor receptor (EGFR) mutation subtypes based on the MRI image of spinal metastases are needed to provide individualized therapy, but has not been previously investigated. This study aims to develop and evaluate an MRI-based radiomics nomogram for differentiating the exon 19 and 21 in EGFR mutation from spinal bone metastases in patients with primary lung adenocarcinoma.
MATERIALS AND METHODS: A total of 76 patients underwent T1-weighted and T2-weighted fat-suppressed MRI scans were enrolled in this study, 38 were positive for EGFR mutation in exon 19 and 38 were in exon 21.MRI imaging features were extracted and selected from each MRI pulse sequence, and used to form the radiomics signature. A radiomics nomogram was developed integrating the radiomics signature and important clinical factors with receiver operating characteristic, calibration and decision curve analysis to assess the nomogram. Clinical characteristics were analyzed with Mann-Whitney U and Chi-Square tests to identify the most important factors.
RESULTS: A total of 6 features were selected as the most discriminative predictors from the two MRI pulse sequences. The nomogram integrating the combined radiomics signature, age and CEA level generated good prediction performance in the training (AUCs, nomogram vs. combined radiomics signature vs. clinical model, 0.90 vs. 0.87 vs. 0.59) and validation (AUCs, nomogram vs. combined radiomics signature vs. clinical model, 0.88 vs. 0.86 vs. 0.72) cohort. DCA analysis confirmed the potential clinical utility of the nomogram.
CONCLUSION: This study demonstrated that MRI features from spinal bone metastases can be used to prognosticate EGFR mutation subtypes in exon 19 and 21. The developed pre-treatment nomogram can potentially guide treatments for lung adenocarcinoma patients.
引用
- Cao R, Dong Y, Wang X, et al. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma. Acad Radiol. 2021. PMID: 34332860. doi:10.1016/j.acra.2021.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。